GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has reported a fire incident at one of its contract manufacturing facilities, which has caused a temporary disruption in production at that site. The company has stated that the impact is currently being assessed. GSK is working closely with the site operator to expedite the resumption of normal operations. No further details on the scale of damage, financial impact, or expected timeline for restart have been provided yet. The disclosure was made under SEBI Listing Regulations on May 16, 2025.
Short-term supply of products made at the affected site may be impacted, which could affect revenue from those specific products until operations resume. Investors should watch for further updates on the extent of damage and the expected timeline for restart, as prolonged disruption could affect earnings.